France's IMPLANET H1 revenue rises on spine implants strength, US growth

Implanet SA

07/07/2026 16:55

Overview
France medical implants maker's H1 2026 revenue rose 23% yr/yr to €7.1 mln
Growth driven by strong US performance and doubled sales of new JSS fixation system
Spine Implants and Medical Equipment segments both contributed to balanced first-half growth

Outlook
Company plans to reinforce U.S. commercial team and accelerate rollout of JAZZ and Sanyou products
IMPLANET aims to expand JAZZ platform distribution in China with Sanyou Medical
Company expects to launch SMTP Quntas range for surgical revision and tumor surgery markets

Result Drivers
JSS FIXATION SYSTEM SALES - Co said doubled sales of new JSS hybrid posterior fixation system drove Spine Implants segment growth
US MARKET EXPANSION - Co said strong performance in United States, now its largest market in Q2, validated commercial investments and international expansion strategy
MEDICAL EQUIPMENT DISTRIBUTION - Co said continued expansion of medical equipment distribution business with SMTP ultrasonic scalpel supported segment growth

Company press release: ID:nBw4Tzsdya

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
EUR 7.1 mln

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)